Cidara Therapeutics, Inc.
CDTX
$220.98
$1.090.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.74% | 203.64% | -11.42% | 49.02% | -22.50% |
| Total Receivables | 0.11% | 9.74% | 0.00% | -0.29% | -27.67% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 12.16% | 2.80% | -1.56% | -53.53% | 1,380.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -0.02% | -0.02% | -0.20% | -- | -- |
| Total Current Assets | -16.73% | 181.60% | -10.39% | 34.42% | -7.01% |
|
|
|||||
| Total Current Assets | -16.73% | 181.60% | -10.39% | 34.42% | -7.01% |
| Net Property, Plant & Equipment | -14.46% | -12.29% | -29.78% | -8.22% | -7.44% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 24,723.16% | -1.04% | 0.00% | -92.27% | 1,094.23% |
| Total Assets | -2.93% | 178.69% | -10.74% | 32.32% | -6.36% |
|
|
|||||
| Total Accounts Payable | 97.23% | -54.95% | 35.73% | 21.60% | 29.68% |
| Total Accrued Expenses | 214.27% | -32.63% | -4.13% | 11.34% | 11.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.21% | 4.18% | -12.48% | 3.86% | 3.88% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 196.55% | -33.79% | -1.50% | 11.76% | 11.85% |
|
|
|||||
| Total Current Liabilities | 196.55% | -33.79% | -1.50% | 11.76% | 11.85% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -49.28% | -32.36% | -36.09% | -18.12% | -14.97% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 190.35% | -33.75% | -2.80% | 10.25% | 10.09% |
|
|
|||||
| Common Stock & APIC | 0.39% | 49.61% | 0.24% | 14.82% | 0.10% |
| Retained Earnings | -12.60% | -4.05% | -3.84% | -9.36% | -2.94% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -15.72% | 253.73% | -13.24% | 41.23% | -11.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -15.72% | 253.73% | -13.24% | 41.23% | -11.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -15.72% | 253.73% | -13.24% | 41.23% | -11.69% |
|
|
|||||